[
  {
    "date": "2021-12-30",
    "symbol": "SEEL",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "000-22245",
    "entityregistrantname": "SEELOS THERAPEUTICS, INC.",
    "entitycentralindexkey": 1017491,
    "entitytaxidentificationnumber": "87-0449967",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "300 Park Avenue",
    "entityaddressaddressline2": "2ndÂ Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10022,
    "cityareacode": 646,
    "localphonenumber": "293-2100",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "SEEL",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "entitylistingparvaluepershare": 0.001,
    "auditorname": "KPMG LLP",
    "auditorlocation": "Short Hills, NJ",
    "auditorfirmid": 185,
    "cash": 78734000,
    "prepaidexpenseandotherassetscurrent": 4727000,
    "assetscurrent": 83461000,
    "operatingleaserightofuseasset": 39000,
    "assets": 83500000,
    "accountspayablecurrent": 1693000,
    "accruedliabilitiescurrent": 3728000,
    "licensespayable": 200000,
    "convertiblesubordinateddebtcurrent": 1030000,
    "derivativeliabilities": 1174000,
    "derivativeliabilitiescurrent": 424000,
    "operatingleaseliabilitycurrent": 38000,
    "liabilitiescurrent": 8287000,
    "convertiblesubordinateddebtnoncurrent": 17890000,
    "liabilities": 26177000,
    "commonstockvalue": 105000,
    "additionalpaidincapitalcommonstock": 198428000,
    "retainedearningsaccumulateddeficit": 141210000,
    "stockholdersequity": 57323000,
    "liabilitiesandstockholdersequity": 83500000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 240000000,
    "commonstocksharesissued": 105500445,
    "commonstocksharesoutstanding": 105500445,
    "researchanddevelopmentexpense": 46649000,
    "generalandadministrativeexpense": 15020000,
    "operatingexpenses": 61669000,
    "operatingincomeloss": -61669000,
    "interestincomedomesticdeposits": 113000,
    "interestexpense": 1598000,
    "derivativelossonderivative": 369000,
    "gainlossinfairvalueofconvertiblenotes": 230000,
    "gainslossesonextinguishmentofdebt": 2387000,
    "gainlossoncontracttermination": 149000,
    "othernonoperatingincomeexpense": -517000,
    "nonoperatingincomeexpense": -4379000,
    "netincomeloss": -66048000,
    "earningspersharebasicanddiluted": -0.73,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 90890061,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8347000,
    "stockissuedduringperiodvaluestockoptionsexercised": 102000,
    "stockissuedduringperiodsharesstockoptionsexercised": 79138,
    "issuanceofcommonstockforlicenseacquired": 3000,
    "issuanceofcommonstockforsettlementofdebt": 1377000,
    "stockissuedduringperiodvaluenewissues": 40000,
    "issuanceofcommonstockforlicenseacquiredshares": 2570266,
    "stockissuedduringperiodsharesnewissues": 39788554,
    "stockissuedduringperiodvalueconversionofconvertiblesecuritiesnetofadjustments": 7000,
    "customissuanceofcommonstockpursuantto2021securitiespurchaseagreement": 540147,
    "issuanceofcommonstockforconversionofdebtshares": 69065,
    "issuanceofcommonstockforextinguishmentofdebtshares": 406250,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 7431125,
    "extinguishmentofbeneficialconversionfeature": -1519000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 138000,
    "stockissuedduringperiodvalueemployeestockownershipplan": 104000,
    "stockissuedduringperiodsharesemployeestockownershipplan": 80009,
    "issuanceofcommonstockpursuantto2021securitiespurchaseagreement": 1000,
    "sharebasedcompensation": 8347000,
    "paymentstoacquireinprocessresearchanddevelopment": 5637000,
    "fairvalueadjustmentofwarrants": 517000,
    "gainlossonforgivenessofnotepayable": -149000,
    "amortizationofdebtdiscountpremium": 1582000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2894000,
    "increasedecreaseinaccountspayable": -194000,
    "increasedecreaseinaccruedliabilities": 1806000,
    "increasedecreaseinotheraccruedliabilities": -125000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": -48995000,
    "repaymentsofnotespayable": 13551000,
    "proceedsfromissuanceofcommonstock": 97957000,
    "proceedsfromconvertibledebt": 20203000,
    "proceedsfromwarrantexercises": 7252000,
    "proceedsfromstockoptionsexercised": 102000,
    "proceedsfromstockplans": 104000,
    "netcashprovidedbyusedinfinancingactivities": 112067000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 63072000,
    "cashandcashequivalentsatcarryingvalue": 78734000,
    "interestpaidnet": 10000,
    "reclassofwarrantliabilitiesrelatedtoserieswarrantsexercisedforcash": 1155000,
    "capitalleaseobligationsincurred": 75000,
    "noncashissuanceofcommonstockforconvertiblenotes": 69000,
    "noncashissuanceofcommonstockforsettlementofdebt": 1377000,
    "noncashextinguishmentofbeneficialconversionfeature": 1519000,
    "issuanceofcommonstockforixbiopharmalicense": 4832000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7306000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0013,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 110,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P0Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 1.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.4,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 424000,
    "fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersoutoflevel3": -1155000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 369000,
    "fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersintolevel3": 19150000,
    "prepaidinsurance": 59000,
    "prepaidclinicalcosts": 4481000,
    "otherprepaidexpensecurrent": 187000,
    "classofwarrantorrightreasonforissuingtononemployees": "TheCompany also issued to the investors warrants to purchase up to 6,648,750 shares of common stock in a concurrent private placement (the\"September 2020 Warrants\"). The September 2020 Warrants have an exercise price of $0.84 per share of common stock, became exercisablebeginning on March 9, 2021 and will expire on March 9, 2026.",
    "offeringproceedsusedtopartiallyrepaycertainconvertiblepromissorynotes": 7300000,
    "classofwarrantorrightoutstanding": 300000,
    "contingentnonrefundableregulatorymilestonepaymentuponsubmissionofapplicationwithfdaorequivalentforeignbodyforparticularlicensedproduct": 750000,
    "contingentnonrefundableregulatorymilestonepaymentuponfdaapprovalofapplicationforparticularlicensedproduct": 3000000,
    "contingentnonrefundableregulatorymilestonepaymentuponregulatoryapprovalinmajormarketforparticularlicensedproduct": 1125000,
    "contingentnonrefundableregulatorymilestonepaymentuponregulatoryapprovalinsecondmajormarketforparticularlicensedproduct": 1125000,
    "contingentnonrefundableregulatorymilestonepaymentinconnectionwithaplindoreuponsubmissionofapplicationwithfdaorequivalentforeignbodyforsuchparticularlicensedproduct": 100000,
    "contingentnonrefundableregulatorymilestonepaymentinconnectionwithaplindoreuponfdaapprovalofapplicationforsuchparticularlicensedproduct": 350000,
    "contingentnonrefundableregulatorymilestonepaymentinconnectionwithaplindoreuponregulatoryapprovalinmajormarketforsuchparticularlicensedproduct": 125000,
    "contingentnonrefundableregulatorymilestonepaymentinconnectionwithaplindoreuponregulatoryapprovalinsecondmajormarketforsuchparticularlicensedproduct": 125000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof1.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponaplindore": 10000000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof1.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponh3receptorantagonist": 10000000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof1.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponacetaminophen": 10000000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof1.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponcrth2antagonists": 10000000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof2.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponaplindore": 20000000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof2.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponh3receptorantagonist": 20000000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof2.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponacetaminophen": 20000000,
    "contingentnonrefundablecommercialmilestonepaymentsinconnectionwithachievementof2.0billionofcumulativeworldwidenetsalesoflicensedproductsbaseduponcrth2antagonists": 20000000,
    "contingentnonrefundablemilestonepaymentuponapprovalbyfdaofndawithrespecttosls002": 10000000,
    "contingentnonrefundablemilestonepaymentuponapprovalbyemaofforeignequivalenttondawithrespecttosls002inmajormarket": 5000000,
    "contingentnonrefundablemilestonepaymentuponapprovalbyemaofforeignequivalenttondawithrespecttosls002insecondmajormarket": 2500000,
    "contingentnonrefundablemilestonepaymentuponachievementof250.0millioninnetsalesofsls002": 5000000,
    "contingentnonrefundablemilestonepaymentuponachievementof500.0millioninnetsalesofsls002": 10000000,
    "contingentnonrefundablemilestonepaymentuponachievementof1.0billioninnetsalesofsls002": 15000000,
    "contingentnonrefundablemilestonepaymentuponachievementof1.5billioninnetsalesofsls002": 20000000,
    "contingentnonrefundablemilestonepaymentuponachievementof2.0billioninnetsalesofsls002": 25000000,
    "contingentnonrefundablemilestonepaymentuponissuanceoffirstpatentdirectedtoanxietyindication": 100000,
    "contingentnonrefundablemilestonesharevalueofcommonstockpaymentuponissuanceoffirstpatentdirectedtoanxietyindication": 150000,
    "contingentnonrefundablemilestonepaymentafterlockingofdatabaseandunblindingdataforstatisticallysignificantreadoutofphaseiiitrialofintranasalracemicketamineproductthathasbeenconductedforsubmissionunder": 500000,
    "contingentnonrefundablemilestonepaymentuponfdaapprovalofndaformilestoneproduct": 3000000,
    "contingentnonrefundablemilestonepaymentuponregulatoryapprovalbyemaformilestoneproduct": 2000000,
    "contingentnonrefundablemilestonepaymentuponregulatoryapprovalinjapanformilestoneproduct": 1500000,
    "maximumamounttobepaidundermilestones": 6600000,
    "percentageofroyaltypayments": 0.0225,
    "contingentadditionalmilestoneconsiderationwithin15daysfollowingcompletionofcompanysfirstphaseiibclinicaltrialoftrehalosesatisfyingcertaincriteria": 8500000,
    "contingentadditionalmilestoneconsiderationwithin15daysfollowingapprovalforcommercializationbyfdaorhealthproductsandfoodbranchofhealthcanadaoffirstndaornewdrugsubmissionrespectivelyoftrehalosefiledbyc": 8500000,
    "futuregrantrevenuecontingentonphaseiibiiisanfilippoclinicaltrial": 1500000,
    "icontingentmilestonepaymentwithin90daysfollowingcompletionofdosingoffirstpatientinphaseiclinicaltrial": 50000,
    "contingentmilestonepaymentwithin90daysfollowingdosingoffirstpatientinphaseiiclinicaltrial": 100000,
    "contingentmilestonepaymentwithin90daysfollowingdosingoffirstpatientinphaseiiiclinicaltrial": 300000,
    "contingentmilestonepaymentwithin90daysfollowingfirstcommercialsalesinu.s.": 1000000,
    "contingentmilestonepaymentwithin90daysfollowingfirstcommercialsalesinanyeuropeanmarket": 1000000,
    "contingentmilestonepaymentwithin90daysfollowing250millionincumulativeworldwidenetsalesoflicensedproduct": 2500000,
    "contingentmilestonepaymentwithin30daysfollowingfilingofindfollowingcompletionofpreclinicalstudiesincludingcomprehensivevalidationofplatform": 100000,
    "contingentmilestonepaymentwithin30daysfollowingdosingoffirstpatientinphaseiclinicaltrial": 200000,
    "contingentmilestonepaymentwithin30daysfollowingdosingoffirstpatientinphaseiiclinicaltrial": 500000,
    "contingentmilestonepaymentwithin30daysfollowingdosingoffirstpatientinphaseiiiclinicaltrial": 1000000,
    "contingentmilestonepaymentwithin30daysfollowingndaapproval": 2000000,
    "accruedprofessionalfeescurrent": 181000,
    "employeerelatedliabilitiescurrent": 1303000,
    "outsideresearchanddevelopmentservicescurrent": 2219000,
    "otheraccruedliabilitiescurrent": 25000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 917000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 11111000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 10194000,
    "longtermdebt": 22222000,
    "convertiblesubordinateddebt": 18900000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.84,
    "numberofwarrantsexercisedduringperiod": 5600000,
    "classofwarrantorrightexercisedexercisepriceofwarrantsorrights": 98,
    "classofwarrantorrightoutstandingweightedaverageremaingcontractuallife": "P2Y4M24D",
    "warrantsexercisable": 1000000,
    "classofwarrantorrightexercisableexercisepriceofwarrantsorrights1": 4.29,
    "classofwarrantorrightexercisableweightedaverageremaingcontractuallife": "P2Y4M24D",
    "commonstockvotingrights": "Eachshare of common stock is entitled to one voting right",
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2021-03-09",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 1.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7306000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2210000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.04,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 49000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2180000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7306000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 2180000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2245000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 856000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 11110431,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.0085,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationdescriptionandterms": "On January 1, 2021, the Company added 545,358 shares for purchaseby employees under the ESPP.",
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 80009,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 72000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "During the year ended December 31, 2021, the Company granted 2,210,000stock options to employees with a weighted average exercise price per share of $4.04 and a 10-year term, subject to the terms and conditionsof the 2012 Plan above. The stockoptions are subject to time vesting requirements. The stock options granted to employees vest 25% on the first anniversary of the grantand monthly thereafter over the next three years.",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 7400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y1M6D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1300000,
    "sharebasedpaymentarrangementnonvestedawardexcludingoptioncostnotyetrecognizedforperformancenotprobableamount": 4100000,
    "deferredtaxassetsoperatinglosscarryforwards": 30751000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsother": 407000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3208000,
    "deferredtaxassetsgoodwillandintangibleassets": 16970000,
    "deferredtaxassetsgross": 51336000,
    "deferredtaxassetsvaluationallowance": 51336000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 12.9,
    "effectiveincometaxratereconciliationdeductionsother": -1.1,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 2.3,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -35.1,
    "operatinglosscarryforwards": 89400000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 400000,
    "operatinglosscarryforwardsexpirationdate": "2036-12-31",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 89000000,
    "deferredtaxassetsgrossnoncurrent": 30800000,
    "opentaxyear": 2018,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 40000,
    "lesseeoperatingleaseliabilitypaymentsdue": 40000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2000,
    "operatingleaseliability": 38000,
    "lesseeoperatingleasedescription": "InMarch 2021, the Company entered into an eighteen-month office space rental agreement for its headquarters at 300 Park Avenue, New York,NY, expiring July 2022. The rental agreement contains a base rent of approximately $4,000 per month.",
    "lesseeoperatingleaseoptiontoextend": "Thisagreement includes one or more renewal options.",
    "operatingleaseweightedaverageremainingleaseterm1": "P292D",
    "operatingleaseweightedaveragediscountratepercent": 8,
    "operatingleaseexpense": 100000
  },
  {
    "date": "2020-12-30",
    "symbol": "SEEL",
    "period": "FY",
    "entityregistrantname": "Seelos Therapeutics, Inc.",
    "tradingsymbol": "SEEL",
    "entitycentralindexkey": 1017491,
    "entitylistingsecuritytradingcurrency": "USD",
    "entitylistingparvaluepershare": 0.001,
    "security12btitle": "Common Stock",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "000-22245",
    "entityincorporationstatecountrycode": "NV",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "cash": 15662000,
    "prepaidexpenseandotherassetscurrent": 1832000,
    "assetscurrent": 17494000,
    "assets": 17494000,
    "accountspayabletradecurrent": 1887000,
    "accruedliabilitiescurrent": 1924000,
    "licensepayables": 125000,
    "convertibledebtcurrent": 2431000,
    "derivativeliabilitiescurrent": 1062000,
    "liabilitiescurrent": 7429000,
    "licensepayableslongterm": 200000,
    "otherlongtermnotespayable": 147000,
    "convertibledebtnoncurrent": 7146000,
    "liabilities": 14922000,
    "commonstockvalue": 54000,
    "additionalpaidincapitalcommonstock": 77680000,
    "retainedearningsaccumulateddeficit": -75162000,
    "stockholdersequity": -75162000,
    "liabilitiesandstockholdersequity": 17494000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 54535891,
    "commonstocksharesoutstanding": 54535891,
    "typeofrevenueextensiblelist": "us-gaap:GrantMember",
    "researchanddevelopmentexpense": 10984000,
    "generalandadministrativeexpense": 7775000,
    "operatingexpenses": 18759000,
    "operatingincomeloss": -18759000,
    "interestincomedomesticdeposits": 45000,
    "interestexpense": 164000,
    "fairvalueadjustmentofwarrants": 223000,
    "nonoperatingincomeexpense": -342000,
    "netincomeloss": -19101000,
    "earningspersharebasicanddiluted": -0.43,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 44766640,
    "sharesoutstanding": 54535891,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2044000,
    "issuanceofcommonstockforprepaidservicesshares": 400000,
    "issuanceofcommonstockforprepaidservices": 330000,
    "issuanceofcommonstockforlicenseacquiredshares": 1809845,
    "issuanceofcommonstockforlicenseacquired": 2441000,
    "stockissuedduringperiodsharesnewissues": 15166666,
    "stockissuedduringperiodvaluenewissues": 8835000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 153628,
    "stockissuedduringperiodvalueconversionofconvertiblesecuritiesnetofadjustments": 169000,
    "issuanceofcommonstockandwarrantspursuanttosecuritiespurchaseagreementnetofissuancecostsshares": 1112219,
    "issuanceofcommonstockandwarrantspursuanttosecuritiespurchaseagreementnetofissuancecosts": 1378000,
    "beneficialconversionfeatureofconvertibledebt": 100000,
    "issuanceofcommonstockandwarrantspursuanttoseptember2020securitiespurchaseagreementnetofissuancecostsshares": 8865000,
    "issuanceofcommonstockandwarrantspursuanttoseptember2020securitiespurchaseagreementnetofissuancecosts": 6356000,
    "sharebasedcompensation": 2044000,
    "issuanceofstockandwarrantsforservicesorclaims": 124000,
    "paymentstoacquireinprocessresearchanddevelopment": 192000,
    "amortizationoffinancingcostsanddiscounts": 150000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 791000,
    "increasedecreaseinaccountspayable": 1091000,
    "increasedecreaseinaccruedliabilities": 5000,
    "increasedecreaseinroyaltiespayable": -4850000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": -20913000,
    "proceedsfromissuanceofcommonstocknetofissuancecosts": 8850000,
    "proceedsfromissuanceofprivateplacement": 6365000,
    "proceedsfromconvertibledebt": 10907000,
    "proceedsfromnotespayable": 147000,
    "proceedsfromwarrantexercises": 45000,
    "netcashprovidedbyusedinfinancingactivities": 26314000,
    "cashandcashequivalentsperiodincreasedecrease": 5401000,
    "cashandcashequivalentsatcarryingvalue": 15662000,
    "interestpaidnet": 11000,
    "stockissued1": 2443000,
    "reclassofwarrantliabilitiesrelatedtoserieswarrantsexercisedforcash": 124000,
    "derivativeliabilities": 1062000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0018,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.017,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.1677,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y0M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.4,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 1062000,
    "fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersoutoflevel3": 124000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -223000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8556000,
    "numberofoperatingsegments": 1,
    "classofwarrantorrightreasonforissuingtononemployees": "On March 16, 2020, the Company completed an underwritten public offering pursuant to which it sold 7,500,000 shares of its common stock at a price to the public of $0.60 per share. The net proceeds to the Company from this offering were approximately $4.0 million, after deducting underwriting discounts and commissions and other offering expenses payable by the Company.",
    "consultingexpense": 431000000,
    "warrantsandrightsoutstanding": 800000,
    "accruedprofessionalfeescurrent": 292000,
    "employeerelatedliabilitiescurrent": 756000,
    "researchanddevelopmentaccruedexpense": 764000,
    "otheraccruedliabilitiescurrent": 112000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 10066000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 6648000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 154000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": 12000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisablenumber": 3.417,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 1.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantsinperiodweightedaverageexerciseprice": 0.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisesinperiodweightedaverageexerciseprice": 0.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsequityinstrumentsforfeitedweightedaverageexerciseprice": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisableweightedaverageexerciseprice": 3.79,
    "assumedinmergerinyears": "P3Y180D",
    "outstandingatbalancesheetdateinyears": "P4Y144D",
    "exercisableatbalancesheetdateinyears": "P2Y252D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 353000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4624000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5120000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 26000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 353000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.97,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 12.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y72D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm": "P9Y108D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y144D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y144D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 196900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 4200,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 4200,
    "allocatedsharebasedcompensationexpense": 394000,
    "deferredtaxassetsoperatinglossandcapitallosscarryforwards": 15223000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 66000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 521000,
    "deferredtaxassetsotherlosscarryforwards": 12320000,
    "deferredtaxassetsgross": 28130000,
    "deferredtaxassetsvaluationallowance": 28130000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.112,
    "effectiveincometaxratereconciliationdeductionsother": -0.01,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.001,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.593,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.906,
    "operatinglosscarryforwards": 90600000,
    "opentaxyear": 2017,
    "taxcreditcarryforwardlimitationsonuse": "The federal and state net operating loss carryforwards, not subject to the annual limitation under Internal Revenue Code Section 382, resulted in a noncurrent deferred tax asset as of December 31, 2020 and 2019 of approximately $15.2 million and $5.6 million, respectively. In consideration of the Company's accumulated losses and the uncertainty",
    "operatingleasesrentexpensenet": 100000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 42000
  },
  {
    "date": "2019-12-30",
    "symbol": "SEEL",
    "period": "FY",
    "entityregistrantname": "Seelos Therapeutics, Inc.",
    "tradingsymbol": "SEEL",
    "entitycentralindexkey": 1017491,
    "entitylistingsecuritytradingcurrency": "USD",
    "entitylistingparvaluepershare": 0.001,
    "security12btitle": "Common Stock",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "000-22245",
    "entityincorporationstatecountrycode": "NV",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "cash": 10261000,
    "prepaidexpenseandotherassetscurrent": 835000,
    "assetscurrent": 11096000,
    "assets": 11096000,
    "accountspayabletradecurrent": 796000,
    "accruedliabilitiescurrent": 1919000,
    "licensepayables": 7100000,
    "derivativeliabilitiescurrent": 963000,
    "liabilitiescurrent": 10778000,
    "licensepayableslongterm": 325000,
    "liabilities": 11103000,
    "commonstockvalue": 27000,
    "additionalpaidincapitalcommonstock": 56027000,
    "retainedearningsaccumulateddeficit": -56061000,
    "stockholdersequity": -56061000,
    "liabilitiesandstockholdersequity": 11096000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 27028533,
    "commonstocksharesoutstanding": 27028533,
    "revenuefromcontractwithcustomerincludingassessedtax": 375000,
    "typeofrevenueextensiblelist": "us-gaap:GrantMember",
    "revenues": 375000,
    "researchanddevelopmentexpense": 22563000,
    "generalandadministrativeexpense": 7559000,
    "operatingexpenses": 30122000,
    "operatingincomeloss": -29747000,
    "interestincomedomesticdeposits": 151000,
    "interestexpense": 29000,
    "recapitalizationcosts": 5020000,
    "fairvalueadjustmentofwarrants": 16501000,
    "changeinfairvalueofconvertiblenotespayable": -109000,
    "nonoperatingincomeexpense": -21508000,
    "netincomeloss": -51255000,
    "earningspersharebasicanddiluted": -2.52,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 20308818,
    "sharesoutstanding": 27028533,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 459000,
    "issuanceofcommonstockandwarrantsinprivateofferingnetof16.5millionwarrantliabilityshares": 1829407,
    "issuanceofcommonstockandwarrantsinprivateofferingnetof16.5millionwarrantliability": 2000,
    "stockissuedduringperiodsharesacquisitions": 947218,
    "stockissuedduringperiodvalueacquisitions": 300000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 14332620,
    "stockissuedduringperiodvalueconversionofconvertiblesecuritiesnetofadjustments": 4503000,
    "issuanceofcommonstockforlicenseacquiredshares": 992782,
    "issuanceofcommonstockforlicenseacquired": 2999000,
    "reclassofwarrantliabilitesrelatedtoserieswarrantsexercisedforcash": 5600000,
    "reclassofseriesbwarrantsfromwarrantliabilitytostockholdersequity": 31473000,
    "issuanceofcommonstockforconversionofdebtandaccruedinterestshares": 172284,
    "issuanceofcommonstockforconversionofdebtandaccruedinterest": 9000,
    "issuanceofcommonstockandwarrantspursuanttosecuritiespurchaseagreementnetofissuancecostsshares": 4475000,
    "issuanceofcommonstockandwarrantspursuanttosecuritiespurchaseagreementnetofissuancecosts": 5915000,
    "issuanceofcommonstockinatthemarketofferingnetofissuancecostsshares": 1197676,
    "issuanceofcommonstockinatthemarketofferingnetofissuancecosts": 2566000,
    "sharebasedcompensation": 459000,
    "paymentstoacquireinprocessresearchanddevelopment": 3000000,
    "increasedecreaseinfairvalueofconvertiblenotespayable": 109000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 686000,
    "increasedecreaseinaccountspayable": -1424000,
    "increasedecreaseinaccruedliabilities": 1533000,
    "increasedecreaseininterestpayablenet": 13000,
    "increasedecreaseinroyaltiespayable": 7100000,
    "increasedecreaseinlicensespayablelongterm": 325000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": -19305000,
    "proceedsfromissuanceofcommonstock": 16520000,
    "proceedsfromissuanceofprivateplacement": 5920000,
    "proceedsfromissuanceofcommonstockinatthemarketoffering": 2567000,
    "proceedsfromwarrantexercises": 4517000,
    "netcashprovidedbyusedinfinancingactivities": 29524000,
    "cashandcashequivalentsperiodincreasedecrease": 10219000,
    "cashandcashequivalentsatcarryingvalue": 10261000,
    "interestpaidnet": 16000,
    "issuanceofcommonstockforconversionofdebt": 2551000,
    "issuanceofcommonstockforconversionofaccruedinterest": 164000,
    "effectofreversemerger": 299000,
    "reclassofwarrantliabilitiesrelatedtoserieswarrantsexercisedforcash": 5600000,
    "derivativeliabilities": 963000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0166,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.026,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.108,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y0M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.06,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 963000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitypurchasessalesissuancessettlements": 21535000,
    "fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersoutoflevel3": 37073000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -16501000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3584000,
    "numberofoperatingsegments": 1,
    "classofwarrantorrightreasonforissuingtononemployees": "Effective August 23, 2019, pursuant to the terms of the Series A Warrants, the exercise price of the Series A Warrants automatically decreased from $1.6736 per share to $0.9267 per share as a result of the announcement of the issuance of the August 2019 Warrants pursuant to the Securities Purchase Agreement.",
    "warrantsandrightsoutstanding": 900000,
    "employeerelatedliabilitiescurrent": 683000,
    "accruedprofessionalfeescurrent": 151000,
    "researchanddevelopmentaccruedexpense": 853000,
    "otheraccruedliabilitiescurrent": 232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 3584000,
    "assumedinmerger": 437000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 17481000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 14334000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisablenumber": 1346000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 3.86,
    "assumedinmergerinusdpershare": 20.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantsinperiodweightedaverageexerciseprice": 0.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisesinperiodweightedaverageexerciseprice": 0.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisableweightedaverageexerciseprice": 7.3,
    "assumedinmergerinyears": "P3Y180D",
    "issuedinyears": "P4Y36D",
    "outstandingatbalancesheetdateinyears": "P3Y108D",
    "exercisableatbalancesheetdateinyears": "P2Y252D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 93000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 477000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y252D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 522000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 93000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.18,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 42.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 42.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm": "P9Y108D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 2100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2100,
    "allocatedsharebasedcompensationexpense": 118000,
    "lessoroperatingleasetermofcontract1": "P1Y",
    "operatingleasesfutureminimumpaymentsduefutureminimumsubleaserentals": 400000,
    "deferredtaxassetsoperatinglossandcapitallosscarryforwards": 5632000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 348000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 84000,
    "deferredtaxassetsotherlosscarryforwards": 4806000,
    "deferredtaxassetsgross": 10870000,
    "deferredtaxassetsvaluationallowance": 10870000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 718000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.067,
    "effectiveincometaxratereconciliationdeductionsother": -0.09,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.184,
    "operatinglosscarryforwards": 42000000,
    "taxcreditcarryforwardlimitationsonuse": "The federal and state net operating loss carryforwards, not subject to the annual limitation under Internal Revenue Code Section 382, resulted in a noncurrent deferred tax asset as of December 31, 2019 and 2018 of approximately $17.7 million and $3.2 million, respectively. In consideration of the Company's accumulated losses and the uncertainty of its ability to utilize this deferred tax asset in the future, the Company has recorded a full valuation allowance as of such dates.",
    "operatingleasesrentexpensenet": 100000,
    "operatingleasesfutureminimumpaymentsduecurrent": 33000
  },
  {
    "date": "2018-12-30",
    "symbol": "SEEL",
    "period": "FY",
    "entityregistrantname": "Seelos Therapeutics, Inc.",
    "tradingsymbol": "SEEL",
    "entitycentralindexkey": 1017491,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "cash": 3579000,
    "prepaidexpenseandotherassetscurrent": 106000,
    "assetscurrent": 3685000,
    "propertyplantandequipmentnet": 38000,
    "otherassetsnoncurrent": 37000,
    "assets": 3760000,
    "accountspayabletradecurrent": 235000,
    "accruedliabilitiescurrent": 644000,
    "accruedemployeebenefitscurrent": 272000,
    "liabilitiesofdisposalgroupincludingdiscontinuedoperationcurrent": 21000,
    "liabilitiescurrent": 1172000,
    "otherliabilitiesnoncurrent": 16000,
    "liabilities": 1188000,
    "commonstockvalue": 28000,
    "additionalpaidincapitalcommonstock": 327773000,
    "retainedearningsaccumulateddeficit": -325229000,
    "stockholdersequity": -325229000,
    "liabilitiesandstockholdersequity": 3760000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 941553,
    "commonstocksharesoutstanding": 941553,
    "researchanddevelopmentexpense": 1220000,
    "generalandadministrativeexpense": 7928000,
    "operatingexpenses": 9148000,
    "operatingincomeloss": -9148000,
    "fairvalueadjustmentofwarrants": -222000,
    "recapitalizationcosts": 293000,
    "othernonoperatingincomeexpense": 1000,
    "nonoperatingincomeexpense": -70000,
    "incomelossfromcontinuingoperations": -9218000,
    "incomelossfromdiscontinuedoperationsnetoftaxattributabletoreportingentity": -24000,
    "netincomeloss": -9242000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -12.11,
    "discontinuedoperationincomelossfromdiscontinuedoperationnetoftaxperbasicanddilutedshare": -0.03,
    "earningspersharebasicanddiluted": -12.14,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 761000,
    "depreciationdepletionandamortization": 41000,
    "sharebasedcompensation": 1301000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -155000,
    "increasedecreaseinothernoncurrentassets": 2000,
    "increasedecreaseinaccountspayable": 177000,
    "increasedecreaseinaccruedliabilities": -6000,
    "increasedecreaseinaccruedsalaries": -591000,
    "increasedecreaseincontractwithcustomerliability": -12000,
    "increasedecreaseinotheroperatingliabilities": -42000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": -8126000,
    "proceedsfromissuanceofcommonstock": 4792000,
    "paymentsofstockissuancecosts": 690000,
    "proceedsfromwarrantexercises": 1275000,
    "netcashprovidedbyusedinfinancingactivities": 5377000,
    "cashprovidedbyusedinoperatingactivitiesdiscontinuedoperations": -3000,
    "netcashprovidedbyusedindiscontinuedoperations": -3000,
    "cashandcashequivalentsperiodincreasedecrease": -2752000,
    "cashandcashequivalentsatcarryingvalue": 3579000,
    "noncashfinancingactivitiesreclassificationofwarrantstoequity": 472000,
    "noncashfinancingactivitiesissuanceofplacementagentwarrants": 159000,
    "sharesoutstanding": 942000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1301000,
    "issuanceofcommonstockandwarrantsshares": 390000,
    "issuanceofcommonstockandwarrantsvalue": 4780000,
    "stockissuedduringperiodsharesvestingofrestrictedstock": 10000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 35000,
    "stockissuedduringperiodvalueconversionofconvertiblesecuritiesnetofadjustments": 1274000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 690000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 293000,
    "warrantliabilityreclassifiedtostockholdersequity": 472000,
    "workingcapital": 4100000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 1000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 387,
    "shelfregistrationstatementavailableamount": 95200000,
    "entitypublicfloatprimarypublicofferingsofsecuritiesthreshold": 75000000,
    "publicfloatprimarypublicofferingsofsecuritiespercentofpublicfloateligibletoberaisedifunderthreshold": 0.3333,
    "propertyplantandequipmentusefullife": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 49.88,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 222000,
    "fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersoutoflevel3": 472000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 437000,
    "numberofoperatingsegments": 1,
    "disposalgroupincludingdiscontinuedoperationcostsofgoodssold": 24000,
    "licensefeespotentialfuturemilestonepaymentsreceivable": 25000000,
    "royaltyratepotentialreceivableonsalesofproductpercentage": 0.1,
    "leaseholdimprovementsgross": 20000,
    "machineryandequipmentgross": 270000,
    "capitalleasedassetsgross": 76000,
    "capitalizedcomputersoftwaregross": 130000,
    "furnitureandfixturesgross": 25000,
    "propertyplantandequipmentgross": 521000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 483000,
    "depreciation": 40000,
    "accruedprofessionalfeescurrent": 548000,
    "researchanddevelopmentaccruedexpense": 4000,
    "otheraccruedliabilitiescurrent": 92000,
    "deferredrentcreditnoncurrent": 4000,
    "customerdepositsnoncurrent": 12000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 437000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 342000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 35000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": 107000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisablenumber": 225000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 20.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantsinperiodweightedaverageexerciseprice": 12.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisesinperiodweightedaverageexerciseprice": 44.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsequityinstrumentsforfeitedweightedaverageexerciseprice": 119.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisableweightedaverageexerciseprice": 30.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 67731,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 10872,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 15076,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 23000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y252D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 29000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 6000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 29000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 230.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 63.3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 183.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 230.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 375,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y288D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y288D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y288D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 9000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 14000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 43.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 49.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 39.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.023,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsforfeiturerate": 0.1133,
    "allocatedsharebasedcompensationexpense": 336000,
    "lessoroperatingleasetermofcontract1": "P1Y",
    "operatingleasesfutureminimumpaymentsduefutureminimumsubleaserentals": 400000,
    "deferredtaxassetsoperatinglossandcapitallosscarryforwards": 25549000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4194000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1937000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsother": 494000,
    "deferredtaxassetsintangibleassetbasisdifference": 3136000,
    "deferredtaxassetsgross": 35310000,
    "deferredtaxassetsvaluationallowance": 35310000,
    "unrecognizedtaxbenefits": 718000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 13000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 8000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.1,
    "effectiveincometaxratereconciliationprioryearincometaxes": -0.05,
    "effectiveincometaxratereconciliationotheradjustments": -0.07,
    "effectiveincometaxratereconciliationtaxcredits": -0.01,
    "operatinglossandcapitallosscarryforwards": 9800000,
    "taxcreditcarryforwardamount": 1800000,
    "deferredtaxassetsoperatinglosscarryforwardsandtaxcreditcarryforwardsdomestic": 27500000,
    "subleasetermofcontract": "P2Y",
    "operatingleasesrentexpensenet": 3000,
    "operatingleasesfutureminimumpaymentsduecurrent": 374000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 32000,
    "operatingleasesfutureminimumpaymentsdue": 406000
  },
  {
    "date": "2017-12-30",
    "symbol": "SEEL",
    "period": "FY",
    "licensefeespotentialfuturemilestonepaymentsreceivable": 25000000,
    "operatingleasesfutureminimumpaymentsduecurrent": 364000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 374000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 32000,
    "operatingleasesfutureminimumpaymentsdue": 770000,
    "operatingleasesrentexpensenet": 300000,
    "severancecompensationagreementterminationorchangeofcontrolperiodforseverancepayments": "P18M",
    "severancecompensationagreementterminationorchangeofcontrolperiodforcontinuedhealthbenefits": "P18M",
    "cashandcashequivalentsatcarryingvalue": 6331000,
    "prepaidexpenseandotherassetscurrent": 261000,
    "assetscurrent": 6592000,
    "propertyplantandequipmentnet": 79000,
    "otherassetsnoncurrent": 35000,
    "assets": 6706000,
    "accountspayabletradecurrent": 58000,
    "accruedliabilitiescurrent": 650000,
    "accruedemployeebenefitscurrent": 863000,
    "deferredrevenuecurrent": 12000,
    "liabilitiescurrent": 1583000,
    "derivativeliabilitiesnoncurrent": 694000,
    "otherliabilitiesnoncurrent": 58000,
    "liabilities": 2335000,
    "commonstockvalue": 15000,
    "additionalpaidincapitalcommonstock": 320343000,
    "retainedearningsaccumulateddeficit": -315987000,
    "stockholdersequity": -315987000,
    "liabilitiesandstockholdersequity": 6706000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 600,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesissued": 15217231,
    "commonstocksharesoutstanding": 15217231,
    "netincomeloss": 321000,
    "incomelossfromdiscontinuedoperationsnetoftaxattributabletoreportingentity": 12070000,
    "incomelossfromcontinuingoperations": -11749000,
    "depreciationdepletionandamortization": 117000,
    "accretionexpenseincludingassetretirementobligations": 56000,
    "sharebasedcompensation": 1138000,
    "fairvalueadjustmentofwarrants": 646000,
    "gainlossesonextinguishmentofdebtnoncashoperating": -422000,
    "othernoncashincomeexpense": -2000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 84000,
    "increasedecreaseinothernoncurrentassets": -25000,
    "increasedecreaseinaccountspayable": -705000,
    "increasedecreaseinaccruedliabilities": -681000,
    "increasedecreaseinaccruedsalaries": 249000,
    "increasedecreaseinotheroperatingliabilities": -7000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": -10571000,
    "proceedsfromissuanceofcommonstock": 10733000,
    "paymentsofstockissuancecosts": 1392000,
    "repaymentsofnotespayable": 7129000,
    "proceedsfromwarrantexercises": 289000,
    "netcashprovidedbyusedinfinancingactivitiescontinuingoperations": 2501000,
    "cashprovidedbyusedinoperatingactivitiesdiscontinuedoperations": 105000,
    "cashprovidedbyusedininvestingactivitiesdiscontinuedoperations": 12209000,
    "netcashprovidedbyusedindiscontinuedoperations": 12314000,
    "cashandcashequivalentsperiodincreasedecrease": 4244000,
    "interestpaid": 92000,
    "noncashfinancingactivitiesreclassificationofwarrantstoequity": 798000,
    "noncashfinancingactivitiesissuanceofplacementagentwarrants": 287000,
    "sharesoutstanding": 15217000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1138000,
    "stockissuedduringperiodsharesvestingofrestrictedstock": 131000,
    "issuanceofcommonstockandwarrantsshares": 7353000,
    "issuanceofcommonstockandwarrantsvalue": 7000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 1392000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 289000,
    "warrantliabilityreclassifiedtostockholdersequity": 798000,
    "researchanddevelopmentexpense": 3463000,
    "generalandadministrativeexpense": 7210000,
    "gainlossondispositionofassets1": -2000,
    "operatingexpenses": 10675000,
    "operatingincomeloss": -10675000,
    "interestincomeexpensenonoperatingnet": -83000,
    "gainslossesonextinguishmentofdebt": -422000,
    "othernonoperatingincomeexpense": 77000,
    "nonoperatingincomeexpense": -1074000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -0.99,
    "incomelossfromdiscontinuedoperationsnetoftaxperbasicanddilutedshare": 1.01,
    "earningspersharebasicanddiluted": 0.02,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11892000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 19000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 12.9,
    "interestexpensedebt": 100000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2017-12-31",
    "documentfiscalyearfocus": 2017,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "APRI",
    "entityregistrantname": "APRICUS BIOSCIENCES, INC.",
    "entitycentralindexkey": 1017491,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Smaller Reporting Company",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 225975,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 293296,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y0M0D",
    "allocatedsharebasedcompensationexpense": 227000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 718000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 872500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 214073,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 55500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 1.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 1.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 369000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 46398,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 355559,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 17.37,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 16.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 17.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 18.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y8M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y8M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y4M12D",
    "disposalgroupincludingdiscontinuedoperationconsideration": 12709000,
    "discontinuedoperationgainlossondisposalofdiscontinuedoperationnetoftax": 12317000,
    "disposalgroupincludingdiscontinuedoperationrevenueroyalty": 368000,
    "disposalgroupincludingdiscontinuedoperationrevenue": 143000,
    "disposalgroupincludingdiscontinuedoperationcostsofgoodssold": 74000,
    "disposalgroupincludingdiscontinuedoperationcostofservices": 10000,
    "disposalgroupincludingdiscontinuedoperationoperatingexpense": 658000,
    "disposalgroupincludingdiscontinuedoperationotherexpense": 16000,
    "deferredtaxassetsoperatinglossandcapitallosscarryforwards": 23463000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4620000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1923000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsother": 721000,
    "deferredtaxassetsintangibleassetbasisdifference": 3658000,
    "deferredtaxassetsgross": 34385000,
    "deferredtaxassetsvaluationallowance": 34385000,
    "operatinglossandcapitallosscarryforwards": 9800000,
    "taxcreditcarryforwardamount": 1000000,
    "deferredtaxassetsoperatinglosscarryforwardsandtaxcreditcarryforwardsdomestic": 25400000,
    "taxcutsandjobsactof2017incompleteaccountingchangeintaxrateprovisionalincometaxexpensebenefit": -19500000,
    "unrecognizedtaxbenefits": 713000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 34000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 2368000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.34,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -1.65,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 3.6,
    "effectiveincometaxratereconciliationprioryearincometaxes": -2.27,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.02,
    "effectiveincometaxratereconciliationotheradjustments": -0.01,
    "effectiveincometaxratereconciliationtaxcredits": -0.01,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7084000,
    "derivativeliabilities": 694000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 694000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -646000,
    "fairvaluemeasurementwithunobservableinputsreconciliationliabilitytransfersoutoflevel3": 798000,
    "fairvalueassumptionsriskfreeinterestrate": 0.022,
    "fairvalueassumptionsexpectedvolatilityrate": 0.89,
    "fairvalueassumptionsexpectedterm": "P5Y0M15D",
    "fairvalueassumptionsexerciseprice": 0.8,
    "salesrevenuenet": 364000,
    "shelfregistrationstatementavailableamount": 100000000,
    "entitypublicfloatprimarypublicofferingsofsecuritiesthreshold": 75000000,
    "publicfloatprimarypublicofferingsofsecuritiespercentofpublicfloateligibletoberaisedifunderthreshold": 0.3333,
    "numberofproductcandidates": 2,
    "propertyplantandequipmentusefullife": "P5Y",
    "numberofoperatingsegments": 1,
    "accruedprofessionalfeescurrent": 575000,
    "researchanddevelopmentaccruedexpense": 61000,
    "otheraccruedliabilitiescurrent": 14000,
    "deferredrentcreditnoncurrent": 46000,
    "customerdepositsnoncurrent": 12000,
    "leaseholdimprovementsgross": 20000,
    "machineryandequipmentgross": 270000,
    "capitalleasedassetsgross": 76000,
    "capitalizedcomputersoftwaregross": 130000,
    "furnitureandfixturesgross": 25000,
    "propertyplantandequipmentgross": 521000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 442000,
    "depreciation": 100000,
    "preferredstockdividendratepercentage": 0.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 7084000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 5199000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 186000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": 247000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisablenumber": 7084000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 3.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgrantsinperiodweightedaverageexerciseprice": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisesinperiodweightedaverageexerciseprice": 1.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsequityinstrumentsforfeitedweightedaverageexerciseprice": 52.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercisableweightedaverageexerciseprice": 3.91
  }
]